
Zvoľte si etiketu
zobrazené priamo na liekovkeARA-290
Healing
- Odosielame z Nemecka
Objednávka
- DHL so sledovaním zásielky
- Diskrétne balenie
V skratke
ARA-290 v číslach
Kľúčové údaje z nášho lexikónu.
Celé heslo v lexikóne- Class
- EPO-derived peptidenon-hematopoietic
- Half-life
- short
- Use
- Subcutaneousin mg
- Sizes
- 10 to 16 mg2 sizes in the shop
What studies show
The source in the lexicon- Heij, Brines et al., Molecular Medicine, 2012
Hodnotenia
Čo hovoria zákazníci
Len skutočné objednávky, ktoré obsahovali ARA-290.
Všetky hodnoteniaPre ARA-290 zatiaľ neexistuje laboratórna analýza. Hlasujte za toDajte si to otestovať sami, polovicu zaplatímeVšetky laboratórne analýzy
Znalosti
Všetko o ARA-290
Podrobné informácie pripravujeme.
Dávkovanie
Načítavajú sa informácie o dávkovaní …
Hodí sa priobjednať
Čo k tomu potrebujete
Bakteriostatická voda sa do košíka pridá automaticky. Striekačky a tampóny jedným kliknutím.
Inzulínové striekačky
10 ks · 5.50 €
Alkoholové tampóny
50 ks · 10 €
Koľko vody?
Jednotky na striekačke pre vašu veľkosť liekovky.
Otvoriť kalkulačku →What is ARA-290?
A small peptide with the drug name cibinetide, designed from the structure of erythropoietin. Unlike EPO it is meant not to make the body form red blood cells. It acts through the innate repair receptor, a complex of the EPO receptor and CD131.
What do the sarcoidosis studies show?
In the first pilot study with 22 participants the symptom score fell by 11.5 points after 4 weeks versus 2.9 with placebo. A second study with daily dosing under the skin for 28 days found fewer symptoms, more nerve fibres in the cornea and a longer walking distance. In the phase 2b trial with 64 participants only the middle study dose was significant.
What about type 2 diabetes?
In a phase 2 trial with daily dosing under the skin for 28 days long-term blood sugar and blood lipids improved over 56 days and so did nerve pain symptoms. In participants with clearly reduced corneal nerve fibre density this density increased, with placebo it did not.
Does ARA-290 help with eye diseases?
In diabetic macular oedema a small study with 9 participants showed no improvement in visual acuity or retinal thickness after 12 weeks. Only the visual function questionnaire came out slightly better. The trial ended early because the study drug expired.
Does ARA-290 affect mood?
In a study with 36 healthy people the brain responded more weakly to happy faces one week after dosing and attention to positive pictures increased. ARA-290 had no effect on mood or emotional state. A clear antidepressant-like profile did not emerge.
Which side effects are known?
No safety concerns appeared in the studies. In diabetic macular oedema there were no serious side effects and no antibodies against the compound after 12 weeks. The abstracts give no percentages for individual side effects.
Súvisiace
Súvisiace produkty
BPC-157
Peptidy · Hojenie a regenerácia Hojenie a regenerácia
4 veľkosti
Laboratórne testované
= od 5.2 €/liekovka
TB-500 (Thymosin B4)
Peptidy · Hojenie a regenerácia Hojenie a regenerácia
3 veľkosti
Laboratórne testované
= od 18.8 €/liekovka
TB-500 FRAG
Peptidy · Hojenie a regenerácia Hojenie a regenerácia
1 veľkosť
= 24.8 €/liekovka
BPC + TB Blend
Peptidy · Hojenie a regenerácia Hojenie a regenerácia
3 veľkosti
Laboratórne testované
= od 24.8 €/liekovka
ARA-290